13.04.2015 16:47:46

One Analyst Changes His Tune on AbbVie and its Pharmacyclics Deal

AbbVie Inc. $21 billion acquisition of pharmaceuticals company Pharmacyclics Inc. might not have been as ...

Weiter zum vollständigen Artikel bei "The Wall Street Journal Deutschland"